Alumis ALMS
NASDAQ ALMS
$7.90 +0.13 (+1.67%)
At close: Sep 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Net Equity Issued and Repurchased (2024)

Alumis' (ALMS) quarterly Net Equity Issued and Repurchased came in at $129.5 million in Q1 2024.

Analysis

Alumis (ALMS) Net Equity Issued and Repurchased (2024) Analysis & Trends

Alumis (ALMS) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $129.5 million the latest figure, recorded in Q1 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 9.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 49.20 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 Alumis 966.94 Mn 464.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 129.50 Mn
API Access

Alumis Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALMS&period=max&api_key=YOUR_API_KEY